Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC Supplementation in Low Glutathione Individuals
NCT03121222Phase 2Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Nov 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in glutathione synthetase deficiency (GSD) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Maximal oxygen consumption at 64 days. Started Nov 2015; status: completed.
02
Drugs
acetylcysteine
03
Conditions
glutathione synthetase deficiency (GSD)
Beyond the preview
Go deeper on NCT03121222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03121222.